Review
Published on 31 Oct 2024
The clinical potential of 1,5-anhydroglucitol as biomarker in diabetes mellitus
in Clinical Diabetes
Frontiers in Endocrinology
doi 10.3389/fendo.2024.1471577
- 437 views
Type at least 3 characters
2,119 articles
Articles
Original Research
Published on 30 Oct 2024
Clinical efficacy and mechanism of the combination of autologous platelet-rich gel and recombinant human acidic fibroblast growth factor in the management of refractory diabetic foot
in Clinical Diabetes
Frontiers in Endocrinology
doi 10.3389/fendo.2024.1374507
- 445 views
Correction
Accepted on 29 Oct 2024
Corrigendum: Familial partial lipodystrophy resulting from loss-offunction PPARγ pathogenic variants: phenotypic, clinical, and genetic features
in Clinical Diabetes
Frontiers in Endocrinology
doi 10.3389/fendo.2024.1508146
Original Research
Published on 29 Oct 2024
The association of the perioperative neutrophil-to-lymphocyte ratio with wound healing in patients with Wagner grade 3 and 4 diabetic foot ulcers after tibial cortex transverse transport surgery: a prospective observational cohort study
in Clinical Diabetes
Frontiers in Endocrinology
doi 10.3389/fendo.2024.1420232
- 551 views
Original Research
Published on 29 Oct 2024
Effects of magnesium and potassium supplementation on insomnia and sleep hormones in patients with diabetes mellitus
in Clinical Diabetes
Frontiers in Endocrinology
doi 10.3389/fendo.2024.1370733
- 834 views
Original Research
Accepted on 28 Oct 2024
Serum 25-hydroxy vitamin D level is associated with elastography detected liver fibrosis in patients with type 2 diabetes mellitus in China
in Clinical Diabetes
Frontiers in Endocrinology
doi 10.3389/fendo.2024.1420088
Original Research
Accepted on 25 Oct 2024
The Correlation Between Diabetes and Age-related Degeneration and the Static and Dynamic 3D Mechanical Distribution of Different Plantar Regions
in Clinical Diabetes
Frontiers in Endocrinology
doi 10.3389/fendo.2024.1433928
- 213 views
Original Research
Accepted on 25 Oct 2024
The causal relationship between type 2 diabetes mellitus and isolated REM sleep behavior disorder: results from multivariable and network Mendelian randomization analysis
in Clinical Diabetes
Frontiers in Endocrinology
doi 10.3389/fendo.2024.1408053
- 102 views
Original Research
Accepted on 25 Oct 2024
Association between calculated remnant cholesterol levels and incident risks of Alzheimer's Disease among elderly patients with type 2 diabetes: a real-world study
in Clinical Diabetes
Frontiers in Endocrinology
doi 10.3389/fendo.2024.1505234
- 119 views
Editorial
Published on 24 Oct 2024
Editorial: Digital technology in the management and prevention of diabetes
in Clinical Diabetes
Frontiers in Endocrinology
doi 10.3389/fendo.2024.1511236
- 539 views
Editorial
Published on 23 Oct 2024
Editorial: Improving outcomes in diabetic foot care - a worldwide perspective
in Clinical Diabetes
Frontiers in Endocrinology
doi 10.3389/fendo.2024.1505838
- 431 views
Original Research
Published on 23 Oct 2024
Temporal trend in quality indicators of diabetes care performance among persons with type 2 diabetes in primary care practice: a serial cross-sectional analytical study, 2013/14 to 2021/22
in Clinical Diabetes
Frontiers in Endocrinology
doi 10.3389/fendo.2024.1359904
- 646 views
Original Research
Published on 22 Oct 2024
The association between triglyceride-glucose index and gallstones: NHANES 2017-2020
in Clinical Diabetes
Frontiers in Endocrinology
doi 10.3389/fendo.2024.1437711
- 633 views
Original Research
Published on 22 Oct 2024
Analysis of risk factors for painful diabetic peripheral neuropathy and construction of a prediction model based on Lasso regression
in Clinical Diabetes
Frontiers in Endocrinology
doi 10.3389/fendo.2024.1477570
- 517 views
Editorial
Published on 21 Oct 2024
Editorial: Effects of nonpharmacological interventions on HbA1c variability and glycemic control
in Clinical Diabetes
Frontiers in Endocrinology
doi 10.3389/fendo.2024.1482920
- 219 views
Original Research
Published on 21 Oct 2024
Comparison of protective effects of teneligliptin and luseogliflozin on pancreatic β-cell function: randomized, parallel-group, multicenter, open-label study (SECRETE-I study)
in Clinical Diabetes
Frontiers in Endocrinology
doi 10.3389/fendo.2024.1412553
- 1,015 views